These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
269 related articles for article (PubMed ID: 25991065)
21. Preparation, evaluation and need of spherical crystallization in case of high speed direct tabletting. Pandey S; Patil AT Curr Drug Deliv; 2014; 11(2):179-90. PubMed ID: 23848355 [TBL] [Abstract][Full Text] [Related]
22. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation. Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058 [TBL] [Abstract][Full Text] [Related]
23. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates. Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224 [TBL] [Abstract][Full Text] [Related]
24. Co-crystallization for enhanced dissolution rate of bicalutamide: preparation and evaluation of rapidly disintegrating tablets. Essa EA; Elbasuony AR; Abdelaziz AE; El Maghraby GM Drug Dev Ind Pharm; 2019 Aug; 45(8):1215-1223. PubMed ID: 30661420 [No Abstract] [Full Text] [Related]
25. Ranking Itraconazole Formulations Based on the Flux through Artificial Lipophilic Membrane. Tsinman K; Tsinman O; Lingamaneni R; Zhu S; Riebesehl B; Grandeury A; Juhnke M; Van Eerdenbrugh B Pharm Res; 2018 Jun; 35(8):161. PubMed ID: 29926245 [TBL] [Abstract][Full Text] [Related]
26. A nanosystem for water-insoluble drugs prepared by a new technology, nanoparticulation using a solid lipid and supercritical fluid. Park JW; Yun JM; Lee ES; Youn YS; Kim KS; Oh YT; Oh KT Arch Pharm Res; 2013 Nov; 36(11):1369-76. PubMed ID: 23780798 [TBL] [Abstract][Full Text] [Related]
28. Downstream drug product processing of itraconazole nanosuspension: Factors influencing tablet material properties and dissolution of compacted nanosuspension-layered sugar beads. Tan EH; Parmentier J; Low A; Möschwitzer JP Int J Pharm; 2017 Oct; 532(1):131-138. PubMed ID: 28859940 [TBL] [Abstract][Full Text] [Related]
29. Development of orally disintegrating tablets of Perphenazine/hydroxypropyl-β-cyclodextrin inclusion complex. Wang L; Zeng F; Zong L Pharm Dev Technol; 2013; 18(5):1101-10. PubMed ID: 22759202 [TBL] [Abstract][Full Text] [Related]
30. Effect of polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer on bioadhesion and release rate property of eplerenone pellets. Kendre PN; Chaudhari PD Drug Dev Ind Pharm; 2017 May; 43(5):751-761. PubMed ID: 27494543 [TBL] [Abstract][Full Text] [Related]
31. Development of Itraconazole Tablets Containing Viscous KinetiSol Solid Dispersions: In Vitro and In Vivo Analysis in Dogs. Keen JM; LaFountaine JS; Hughey JR; Miller DA; McGinity JW AAPS PharmSciTech; 2018 Jul; 19(5):1998-2008. PubMed ID: 29192405 [TBL] [Abstract][Full Text] [Related]
32. Improved compressibility, flowability, dissolution and bioavailability of pioglitazone hydrochloride by emulsion solvent diffusion with additives. Patil SV; Pawar AP; Sahoo SK Pharmazie; 2012 Mar; 67(3):215-23. PubMed ID: 22530302 [TBL] [Abstract][Full Text] [Related]
33. Itraconazole solid dispersion prepared by a supercritical fluid technique: preparation, in vitro characterization, and bioavailability in beagle dogs. Yin X; Daintree LS; Ding S; Ledger DM; Wang B; Zhao W; Qi J; Wu W; Han J Drug Des Devel Ther; 2015; 9():2801-10. PubMed ID: 26060397 [TBL] [Abstract][Full Text] [Related]
34. Particle design of naproxen-disintegrant agglomerates for direct compression by a crystallo-co-agglomeration technique. Maghsoodi M; Taghizadeh O; Martin GP; Nokhodchi A Int J Pharm; 2008 Mar; 351(1-2):45-54. PubMed ID: 17980983 [TBL] [Abstract][Full Text] [Related]
35. Biodegradable Porous Starch Spheres as a Novel Carrier for Enhancement of Dissolution Rate and Oral Bioavailability of Itraconazole. Pawar J; Ali MT; Fule R; Moravkar K; Seervi M; Sathaye S; Amin P Curr Drug Deliv; 2017; 14(7):944-954. PubMed ID: 27654575 [TBL] [Abstract][Full Text] [Related]
36. Impact of surface area of silica particles on dissolution rate and oral bioavailability of poorly water soluble drugs: a case study with aceclofenac. Kumar D; Sailaja Chirravuri SV; Shastri NR Int J Pharm; 2014 Jan; 461(1-2):459-68. PubMed ID: 24368106 [TBL] [Abstract][Full Text] [Related]
37. Cefdinir nanosuspension for improved oral bioavailability by media milling technique: formulation, characterization and in vitro-in vivo evaluations. Sawant KK; Patel MH; Patel K Drug Dev Ind Pharm; 2016; 42(5):758-68. PubMed ID: 26548349 [TBL] [Abstract][Full Text] [Related]
38. Soluplus® as an effective absorption enhancer of poorly soluble drugs in vitro and in vivo. Linn M; Collnot EM; Djuric D; Hempel K; Fabian E; Kolter K; Lehr CM Eur J Pharm Sci; 2012 Feb; 45(3):336-43. PubMed ID: 22172603 [TBL] [Abstract][Full Text] [Related]
39. Xylitol as a potential co-crystal co-former for enhancing dissolution rate of felodipine: preparation and evaluation of sublingual tablets. Arafa MF; El-Gizawy SA; Osman MA; El Maghraby GM Pharm Dev Technol; 2018 Jun; 23(5):454-463. PubMed ID: 27681386 [TBL] [Abstract][Full Text] [Related]